Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Amorolfine Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Eurofins Dermscan
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 15, 2024
Lead Product(s) : Amorolfine Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Eurofins Dermscan
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amorolfine Hydrochloride
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Loceryl Nail Lacquer
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 10, 2016
Lead Product(s) : Amorolfine Hydrochloride
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amorolfine Hydrochloride
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail Lacquer
Details : Undisclosed
Product Name : Loceryl
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 11, 2016
Lead Product(s) : Amorolfine Hydrochloride
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amorolfine Hydrochloride
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Antifungal Activity of Loceryl Nail Lacquer in Combination With a Cosmetic Varnish
Details : Undisclosed
Product Name : Loceryl
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 22, 2014
Lead Product(s) : Amorolfine Hydrochloride
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable